Unsal Tan O, Vagolu SK, Tønjum T, Kaplan O, Simsek R (2025)
Promising Antimycobacterial Agents: Salicylidenehydrazines
Arch Pharm (Weinheim), 358 (7), e70065
DOI 10.1002/ardp.70065, PubMed 40726231

Dwt N, Leon De La Fuente R, Gallo P, Naesgaard P, Dib Ashur S, Michelsen AE, Aukrust P, Staines H, Ueland T (2025)
High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up
Int J Cardiol, 439, 133674 (in press)
DOI 10.1016/j.ijcard.2025.133674, PubMed 40716679

Andersen T, Ueland T, Aukrust P, Nilsen DW, Grundt H, Staines H, Kontny F (2025)
Correction: Podocan and adverse clinical outcome in patients admitted with suspected acute coronary syndromes
Front Cardiovasc Med, 12, 1650098
DOI 10.3389/fcvm.2025.1650098, PubMed 40693227